With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.

According to Valuates Reports, The global market for AI in Biotechnology was valued at USD 1033 Million in the year 2024 and is projected to reach a revised size of USD 1971 Million by 2031, growing ...

Molecular Instruments® (MI), inventor of the HCRtm technology, today announced the availability of fully ambient-temperature HCRtm Pro RNA-ISH on the BOND-III, introducing a new class of ...